Connect with us

Hi, what are you looking for?

Stock

European shares flat as rising industrial shares offset healthcare losses

By Nikhil Sharma and Shashwat Chauhan

(Reuters) -Europe’s STOXX 600 struggled for direction on Tuesday as rising industrials and financial services shares offset losses in healthcare stocks, with the focus on key inflation data across the continent due later in the day.

Europe’s premier index reversed initial losses and held steady at 513.28 points, trading at its highest level in three weeks.

Financial services rose 0.9% and was amongst the top STOXX sub-sectors, boosted by a nearly 5% rise in Partners Group after UBS upgraded its rating on the buyout firm to “buy”.

Retailers gained 0.8% as UK’s Next (LON:NXT) advanced 2.7%, after the clothing retailer lifted its annual profit outlook for the fourth time in six months.

Industrial goods and services gained 0.3%, boosted by a 9.8% rise in heavy machinery & vehicles supplier Kion Group. The company has partnered with Nvidia (NASDAQ:NVDA) and IT services provider Accenture (NYSE:ACN) to optimise supply chains with AI technologies.

A 4.7% jump in Volvo (OTC:VLVLY) also aided gains.

On the downside, healthcare fell 0.4%. Index heavyweight Novo Nordisk (NYSE:NVO) lost 2.3% and AstraZeneca (NASDAQ:AZN) was 1.2% lower.

The pan-European benchmark had jumped nearly 1% in the last session following a report that suggested U.S. President-elect Donald Trump may opt for a less aggressive tariff strategy.

Trump later denied the report, adding to the uncertainty in the days leading up to the former president’s Jan. 20 inauguration.

“Rumours and denials have a history of misguiding investors and causing temporary dislocations across a range of assets,” analysts at Societe Generale (OTC:SCGLY) wrote in a note.

“Yesterday was a prime example of how stories, originating from reputable channels, can distort daily flows.”

The focus will be on a euro zone inflation reading due later in the session that could offer more insights into the European Central Bank’s interest rate outlook.

French consumer prices rose less than anticipated in December, while Swiss inflation fell again, fuelling expectations for more interest rate cuts by the Swiss National Bank.

European equities lagged their global counterparts last year as looming tariff threats, a slowing economy and geopolitical uncertainty in top economies France and Germany kept investors on edge.

Deutsche Bank (ETR:DBKGn) said it is now “overweight” on European equities due to an improving political climate, macro conditions and potential stimulus measures from China in 2025.

Among other notable stocks, Sodexo (EPA:EXHO) slid 8.4% after the French food caterer missed market expectations on first-quarter organic revenue.

This post appeared first on investing.com






    You May Also Like

    Economy

    A U.N. human rights group confirmed Hamas’ leader in Lebanon, who was recently killed by Israeli strikes, was their employee.  Fateh Sherif was killed...

    Investing

    Astron (ASX:ATR) and Energy Fuels (TSX:EFR,NYSEAMERICAN:UUUU) have completed the establishment of a joint venture to advance the Australia-based Donald rare earths and mineral sands...

    Editor's Pick

    Sen. JD Vance (R-Ohio) and Minnesota Gov. Tim Walz (D) will face off Tuesday night at a CBS News vice-presidential debate in New York....

    Latest News

    A North Korean defector who escaped to the South more than a decade ago was detained after attempting to cross back into North Korea...

    Disclaimer: balanceandcharge.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2024 balanceandcharge.com